BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Covington
Queensland Health
Express Scripts
Teva
Healthtrust
QuintilesIMS
Federal Trade Commission
Deloitte
Cerilliant

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,088,750

« Back to Dashboard

Summary for Patent: 4,088,750
Title: Method and preparation for increasing bioavailability of digoxin
Abstract:Method and preparation for increasing the bioavailability of digoxin to treat cardiac insufficiency in a human, said method comprising the administration of a preparation comprising a capsule adapted to release a solution of digoxin in an amount sufficient to treat cardiac insufficiency.
Inventor(s): Cresswell; Ronald M. (Raleigh, NC), Holstius; Elvin A. (Greenville, NC)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:05/653,246
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;

Drugs Protected by US Patent 4,088,750

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,088,750

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 366576 ➤ Subscribe
Austria A133175 ➤ Subscribe
Australia 501549 ➤ Subscribe
Australia 520082 ➤ Subscribe
Australia 7844075 ➤ Subscribe
Belgium 825842 ➤ Subscribe
Canada 1096307 ➤ Subscribe
Germany 2507635 ➤ Subscribe
Spain 434971 ➤ Subscribe
Finland 750489 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Cipla
McKesson
Mallinckrodt
Accenture
Julphar
Chubb
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot